Rabab A. Charafeddine
Albert Einstein College of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rabab A. Charafeddine.
The FASEB Journal | 2010
Coert Margadant; Rabab A. Charafeddine; Arnoud Sonnenberg
The skin forms a barrier against the environment and protects us from mechanical trauma, pathogens, radiation, dehydration, and dangerous temperature fluctuations. The epithelium of the skin, the epidermis, is in a continuous equilibrium of growth and differentiation and has the remarkable capacity to self‐renew completely, which relies on reservoirs of stem cells. Epidermal homeostasis is further dependent on proper repair after injury, and on tight adhesion to the underlying basement membrane. Epidermal adhesion is mediated primarily by integrins, cell‐surface receptors that connect the extracellular matrix to the cytoskeleton. In addition, numerous in vitro reports have implicated integrins, integrin‐associated proteins, or downstream integrin effectors in the regulation of a plethora of cellular processes other than adhesion. Over the past decade, a wealth of information on the function of these proteins has been gathered both from (conditional) knockout mice and from human skin disorders, allowing for a reconstruction of integrin signaling pathways in vivo. Here, we address how epidermal integrins and integrin‐associated proteins regulate keratinocyte adhesion, proliferation, and differentiation, as well as signal transduction, re‐epithelialization during wound healing, hair growth, and stem cell maintenance. Furthermore, we discuss human pathologies associated with altered integrin functions in the epidermis.—Margadant, C., Charafeddine, R. A., Sonnenberg, A. Unique and redundant functions of integrins in the epidermis. FASEB J. 24, 4133–4152 (2010). www.fasebj.org
Cell Cycle | 2012
Suranjana Mukherjee; J. Daniel Diaz Valencia; Shannon Stewman; Jeremy Metz; Sylvain Monnier; Uttama Rath; Ana B. Asenjo; Rabab A. Charafeddine; Hernando Sosa; Jennifer L. Ross; Ao Ma; David J. Sharp
Fidgetin is a member of the AAA protein superfamily with important roles in mammalian development. Here we show that human Fidgetin is a potent microtubule severing and depolymerizing the enzyme used to regulate mitotic spindle architecture, dynamics and anaphase A. In vitro, recombinant human Fidgetin severs taxol-stabilized microtubules along their length and promotes depolymerization, primarily from their minus-ends. In cells, human Fidgetin targets to centrosomes, and its depletion with siRNA significantly reduces the velocity of poleward tubulin flux and anaphase A chromatid-to-pole motion. In addition, the loss of Fidgetin induces a microtubule-dependent enlargement of mitotic centrosomes and an increase in the number and length of astral microtubules. Based on these data, we propose that human Fidgetin actively suppresses microtubule growth from and attachment to centrosomes.
Journal of Investigative Dermatology | 2015
Rabab A. Charafeddine; Joy Makdisi; David Schairer; Brian P. O'Rourke; Juan D. Diaz-Valencia; Jason Chouake; Allison Kutner; Aimee E. Krausz; Brandon L. Adler; Parimala Nacharaju; Hongying Liang; Suranjana Mukherjee; Joel M. Friedman; Adam J. Friedman; Joshua D. Nosanchuk; David J. Sharp
Wound healing is a complex process driven largely by the migration of a variety of distinct cell types from the wound margin into the wound zone. In this study, we identify the previously uncharacterized microtubule-severing enzyme, Fidgetin-like 2 (FL2), as a fundamental regulator of cell migration that can be targeted in vivo using nanoparticle-encapsulated small interfering RNA (siRNA) to promote wound closure and regeneration. In vitro, depletion of FL2 from mammalian tissue culture cells results in a more than twofold increase in the rate of cell movement, in part due to a significant increase in directional motility. Immunofluorescence analyses indicate that FL2 normally localizes to the cell edge, importantly to the leading edge of polarized cells, where it regulates the organization and dynamics of the microtubule cytoskeleton. To clinically translate these findings, we utilized a nanoparticle-based siRNA delivery platform to locally deplete FL2 in both murine full-thickness excisional and burn wounds. Topical application of FL2 siRNA nanoparticles to either wound type results in a significant enhancement in the rate and quality of wound closure both clinically and histologically relative to controls. Taken together, these results identify FL2 as a promising therapeutic target to promote the regeneration and repair of cutaneous wounds.
Nature Communications | 2017
Yidong Wang; Bingruo Wu; Pengfei Lu; Donghong Zhang; Brian Wu; Shweta Varshney; Gonzalo del Monte-Nieto; Zhenwu Zhuang; Rabab A. Charafeddine; Adam H. Kramer; Nicolas E. Sibinga; Nikolaos G. Frangogiannis; Richard N. Kitsis; Ralf H. Adams; Kari Alitalo; David J. Sharp; Richard P. Harvey; Pamela Stanley; Bin Zhou
Coronary artery anomalies may cause life-threatening cardiac complications; however, developmental mechanisms underpinning coronary artery formation remain ill-defined. Here we identify an angiogenic cell population for coronary artery formation in mice. Regulated by a DLL4/NOTCH1/VEGFA/VEGFR2 signaling axis, these angiogenic cells generate mature coronary arteries. The NOTCH modulator POFUT1 critically regulates this signaling axis. POFUT1 inactivation disrupts signaling events and results in excessive angiogenic cell proliferation and plexus formation, leading to anomalous coronary arteries, myocardial infarction and heart failure. Simultaneous VEGFR2 inactivation fully rescues these defects. These findings show that dysregulated angiogenic precursors link coronary anomalies to ischemic heart disease.Though coronary arteries are crucial for heart function, the mechanisms guiding their formation are largely unknown. Here, Wang et al. identify a unique, endocardially-derived angiogenic precursor cell population for coronary artery formation in mice and show that a DLL4/NOTCH1/VEGFA/VEGFR2 signaling axis is key for coronary artery development.
Nature Cell Biology | 2018
Jeffrey van Haren; Rabab A. Charafeddine; Andreas Ettinger; Hui Wang; Klaus M. Hahn; Torsten Wittmann
End-binding proteins (EBs) are adaptors that recruit functionally diverse microtubule plus-end-tracking proteins (+TIPs) to growing microtubule plus ends. To test with high spatial and temporal accuracy how, when and where +TIP complexes contribute to dynamic cell biology, we developed a photo-inactivated EB1 variant (π-EB1) by inserting a blue-light-sensitive protein–protein interaction module between the microtubule-binding and +TIP-binding domains of EB1. π-EB1 replaces endogenous EB1 function in the absence of blue light. By contrast, blue-light-mediated π-EB1 photodissociation results in rapid +TIP complex disassembly, and acutely and reversibly attenuates microtubule growth independent of microtubule end association of the microtubule polymerase CKAP5 (also known as ch-TOG and XMAP215). Local π-EB1 photodissociation allows subcellular control of microtubule dynamics at the second and micrometre scale, and elicits aversive turning of migrating cancer cells. Importantly, light-mediated domain splitting can serve as a template to optically control other intracellular protein activities.van Haren et al. develop a tool to rapidly dissociate proteins from the growing end of microtubules through photo-induced disassembly of end-binding protein 1 (EB1), and find that this reduces microtubule growth and alters cell migration.
Advances in wound care | 2016
Rabab A. Charafeddine; Joshua D. Nosanchuk; David J. Sharp
The Journal of Sexual Medicine | 2018
L. Baker; Moses Tar; Rabab A. Charafeddine; Parimala Nacharaju; Joel M. Friedman; David J. Sharp; Kelvin P. Davies
Biophysical Journal | 2018
Jeffrey van Haren; Rabab A. Charafeddine; Andreas Ettinger; Hui Wang; Klaus M. Hahn; Torsten Wittmann
The Journal of Sexual Medicine | 2017
L. Baker; Moses Tar; Rabab A. Charafeddine; Parimala Nacharaju; Joel M. Friedman; David J. Sharp; Kelvin P. Davies
The Journal of Sexual Medicine | 2017
L. Baker; Moses Tar; Rabab A. Charafeddine; Parimala Nacharaju; Joel M. Friedman; David J. Sharp; Kelvin P. Davies